spacer
spacer

PDBsum entry 2feh

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Oxidoreductase PDB id
2feh

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
333 a.a.
Ligands
DB0-DB0
DB0-DB0-DB0
Theoretical model
PDB id:
2feh
Name: Oxidoreductase
Title: Analysis of cgp-3466 docking to human placental gapdh
Structure: Glyceraldehyde-3-phosphate dehydrogenase, liver. Chain: o, p, q, r. Synonym: gapdh. Engineered: yes
Source: Homo sapiens. Human. Gene: gapd. Expressed in: escherichia coli.
Authors: J.L.Jenkins,J.J.Tanner
Key ref:
J.L.Jenkins and J.J.Tanner (2006). High-resolution structure of human D-glyceraldehyde-3-phosphate dehydrogenase. Acta Crystallogr D Biol Crystallogr, 62, 290-301. PubMed id: 16510976 DOI: 10.1107/S0907444905042289
Date:
15-Dec-05     Release date:   07-Mar-06    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P04406  (G3P_HUMAN) -  Glyceraldehyde-3-phosphate dehydrogenase
Seq:
Struc:
335 a.a.
333 a.a.
Key:    PfamA domain  Secondary structure

 Enzyme reactions 
   Enzyme class: E.C.1.2.1.12  - glyceraldehyde-3-phosphate dehydrogenase (phosphorylating).
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]

      Pathway:
Glyceraldehyde-3-phosphate Dehydrogenase (phosphorylating)
      Reaction: D-glyceraldehyde 3-phosphate + phosphate + NAD+ = (2R)-3-phospho- glyceroyl phosphate + NADH + H+
D-glyceraldehyde 3-phosphate
+ phosphate
+ NAD(+)
= (2R)-3-phospho- glyceroyl phosphate
+ NADH
+ H(+)
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
DOI no: 10.1107/S0907444905042289 Acta Crystallogr D Biol Crystallogr 62:290-301 (2006)
PubMed id: 16510976  
 
 
High-resolution structure of human D-glyceraldehyde-3-phosphate dehydrogenase.
J.L.Jenkins, J.J.Tanner.
 
  ABSTRACT  
 
GAPDH (D-glyceraldehyde-3-phosphate dehydrogenase) is a multifunctional protein that is a target for the design of antitrypanosomatid and anti-apoptosis drugs. Here, the first high-resolution (1.75 Angstroms) structure of a human GAPDH is reported. The structure shows that the intersubunit selectivity cleft that has been leveraged in the design of antitrypanosomatid compounds is closed in human GAPDH. Modeling of an anti-trypanosomatid GAPDH inhibitor in the human GAPDH active site provides insights into the basis for the observed selectivity of this class of inhibitor. Moreover, the high-resolution data reveal a new feature of the cleft: water-mediated intersubunit hydrogen bonds that assist closure of the cleft in the human enzyme. The structure is used in a computational ligand-docking study of the small-molecule compound CGP-3466, which inhibits apoptosis by preventing nuclear accumulation of GAPDH. Plausible binding sites are identified in the adenosine pocket of the NAD(+)-binding site and in a hydrophobic channel located in the center of the tetramer near the intersection of the three molecular twofold axes. The structure is also used to build a qualitative model of the complex between GAPDH and the E3 ubiquitin ligase Siah1. The model suggests that the convex surface near GAPDH Lys227 interacts with a large shallow groove of the Siah1 dimer. These results are discussed in the context of the recently discovered NO-S-nitrosylation-GAPDH-Siah1 apoptosis cascade.
 
  Selected figure(s)  
 
Figure 7.
Figure 7 Structures of HsGAPDH and Siah1 highlighting regions that are important for GAPDH-Siah1 association. (a) HsGAPDH tetramer viewed down the R axis. Subunits are colored as follows: O, yellow; P, red; Q, green; R, blue. Residues that are essential for complex formation with Siah1 are colored gray (residues 222-240) and atoms of Lys227 are drawn as spheres. (b) Homodimer of Siah1 from PDB entry 1k2f (Polekhina et al., 2002[Polekhina, G., House, C. M., Traficante, N., Mackay, J. P., Relaix, F., Sassoon, D. A., Parker, M. W. & Bowtell, D. D. (2002). Nature Struct. Biol. 9, 68-75.]). The two subunits of Siah1 are colored cyan and violet. Residues that are essential for interaction with GAPDH are colored yellow (residues 270-282).
Figure 8.
Figure 8 Qualitative model of the HsGAPDH-Siah1 complex. (a) Docked complex having the top score from PatchDock. A GAPDH subunit is shown in green and the Siah1 dimer is shown in cyan/violet. Only one subunit of the GAPDH dimer used for docking is shown for clarity. GAPDH residues 222-240 are colored gray. Siah1 residues 270-282 are colored yellow. GAPDH Lys227 and Siah1 Ser280 are drawn as spheres. (b) Model of a GAPDH tetramer interacting with four Siah1 dimers. This model was generated from the model in (a) using the symmetry of the GAPDH tetramer. The view is looking down the GAPDH R axis. GAPDH subunits are colored as follows: O, yellow; P, red; Q, green; R, blue. Siah1 dimers are colored cyan/violet and salmon/slate. (c) Surface representation of the model shown in (b).
 
  The above figures are reprinted by permission from the IUCr: Acta Crystallogr D Biol Crystallogr (2006, 62, 290-301) copyright 2006.  
  Figures were selected by the author.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
  20164570 D.A.Butterfield, S.S.Hardas, and M.L.Lange (2010).
Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease: many pathways to neurodegeneration.
  J Alzheimers Dis, 20, 369-393.  
21314614 K.A.Chernorizov, J.L.Elkina, P.I.Semenyuk, V.K.Svedas, and V.I.Muronetz (2010).
Novel Inhibitors of Glyceraldehyde-3-phosphate Dehydrogenase: Covalent Modification of NAD-Binding Site by Aromatic Thiols.
  Biochemistry (Mosc), 75, 1444-1449.  
20140087 Y.W.Lam, Y.Yuan, J.Isaac, C.V.Babu, J.Meller, and S.M.Ho (2010).
Comprehensive identification and modified-site mapping of S-nitrosylated targets in prostate epithelial cells.
  PLoS One, 5, e9075.  
19542219 J.Frayne, A.Taylor, G.Cameron, and A.T.Hadfield (2009).
Structure of insoluble rat sperm glyceraldehyde-3-phosphate dehydrogenase (GAPDH) via heterotetramer formation with Escherichia coli GAPDH reveals target for contraceptive design.
  J Biol Chem, 284, 22703-22712.
PDB codes: 2vyn 2vyv
19800890 N.A.Demarse, S.Ponnusamy, E.K.Spicer, E.Apohan, J.E.Baatz, B.Ogretmen, and C.Davies (2009).
Direct binding of glyceraldehyde 3-phosphate dehydrogenase to telomeric DNA protects telomeres against chemotherapy-induced rapid degradation.
  J Mol Biol, 394, 789-803.  
19997558 U.Sengupta, S.Ukil, N.Dimitrova, and S.Agrawal (2009).
Expression-based network biology identifies alteration in key regulatory pathways of type 2 diabetes and associated risk/complications.
  PLoS One, 4, e8100.  
18654858 S.A.Madsen-Bouterse, and R.A.Kowluru (2008).
Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives.
  Rev Endocr Metab Disord, 9, 315-327.  
18776186 S.Azam, N.Jouvet, A.Jilani, R.Vongsamphanh, X.Yang, S.Yang, and D.Ramotar (2008).
Human Glyceraldehyde-3-phosphate Dehydrogenase Plays a Direct Role in Reactivating Oxidized Forms of the DNA Repair Enzyme APE1.
  J Biol Chem, 283, 30632-30641.  
18057019 S.D.Dunn, L.M.Wahl, and G.B.Gloor (2008).
Mutual information without the influence of phylogeny or entropy dramatically improves residue contact prediction.
  Bioinformatics, 24, 333-340.  
17595071 H.Kim, L.Deng, X.Xiong, W.D.Hunter, M.C.Long, and M.C.Pirrung (2007).
Glyceraldehyde 3-phosphate dehydrogenase is a cellular target of the insulin mimic demethylasterriquinone B1.
  J Med Chem, 50, 3423-3426.  
17613523 H.Nakajima, W.Amano, A.Fujita, A.Fukuhara, Y.T.Azuma, F.Hata, T.Inui, and T.Takeuchi (2007).
The active site cysteine of the proapoptotic protein glyceraldehyde-3-phosphate dehydrogenase is essential in oxidative stress-induced aggregation and cell death.
  J Biol Chem, 282, 26562-26574.  
17251035 S.D.Weeks, M.Drinker, and P.J.Loll (2007).
Ligation independent cloning vectors for expression of SUMO fusions.
  Protein Expr Purif, 53, 40-50.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.

 

spacer

spacer